Vertex Pharmaceuticals Incorporated shares owned by Bowen, Hanes & Company
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Bowen, Hanes & Company
from 13F filings
Historical chart of Bowen, Hanes & Company investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Bowen, Hanes & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Bowen, Hanes & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $83M | 179k | 465.08 |
| 2024-06-30 | $84M | 180k | 468.72 |
| 2024-03-31 | $74M | 178k | 418.01 |
| 2023-12-31 | $71M | 174k | 406.89 |
| 2023-09-30 | $61M | 175k | 347.74 |
| 2023-06-30 | $61M | 173k | 351.91 |
| 2023-03-31 | $55M | 175k | 315.07 |
| 2022-12-31 | $51M | 175k | 288.78 |
| 2022-09-30 | $52M | 181k | 289.54 |
| 2022-06-30 | $54M | 192k | 281.79 |
| 2022-03-31 | $50M | 193k | 260.97 |
| 2021-12-31 | $43M | 194k | 219.60 |
| 2021-09-30 | $32M | 179k | 181.39 |
| 2021-06-30 | $30M | 150k | 201.63 |
| 2021-03-31 | $28M | 131k | 214.89 |
| 2020-12-31 | $31M | 131k | 236.34 |
| 2020-09-30 | $36M | 131k | 272.12 |
| 2020-06-30 | $38M | 131k | 290.31 |
| 2020-03-31 | $32M | 135k | 237.95 |
| 2019-12-31 | $30M | 135k | 218.95 |
| 2019-09-30 | $25M | 150k | 169.42 |
| 2019-06-30 | $28M | 150k | 183.38 |
| 2019-03-31 | $28M | 150k | 183.95 |
| 2018-12-31 | $25M | 150k | 165.71 |
| 2018-09-30 | $32M | 165k | 192.74 |
| 2018-06-30 | $28M | 165k | 169.96 |
| 2018-03-31 | $27M | 165k | 162.98 |
| 2017-12-31 | $25M | 165k | 149.86 |
| 2017-09-30 | $25M | 165k | 152.04 |
| 2017-06-30 | $23M | 180k | 128.87 |
| 2017-03-31 | $20M | 180k | 109.35 |
| 2016-12-31 | $7.4M | 100k | 73.67 |
More positions owned by Bowen, Hanes & Company
Home Depot (HD)
View all positions for Bowen, Hanes & Company
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated